Logo Menu Black - Therapixel
logo
  • Home
  • About Us
    • Team
    • Careers
  • Product & Technology
  • Investors
  • News & Events
    • Press
  • Contact

Presse release

CE Marking

January 12, 2021

Therapixel receives the CE mark for its Artificial Intelligence-based software (AI) MammoScreen™

This cutting-edge technology assists radiologists in the…

by Ekaterina Sinichkina

Text

Logo Therapixel
 
Therapixel is one of the leading French software companies specialising in artificial intelligence applied to medical imaging.

LATEST BLOG NEWS

  • Therapixel releases a new version of MammoScreen® that leverages prior exams for better accuracy May 14, 2022
  • Therapixel announces close of 15 M€ series B financing to deploy MammoScreen® 2D/3D May 12, 2022
  • Therapixel receives FDA clearance for use of its AI-based breast cancer screening software MammoScreen® on Digital Breast Tomosynthesis November 28, 2021

RECOMMENDED POSTS

  • Therapixel secures a €5 million Series A financing and strengthens its governance
  • Therapixel receives FDA 510(k) clearance for MammoScreen™
  • Therapixel is now ISO/IEC 27001 certified
  • Therapixel participates in the Journées Francophones de Radiologie 2020
  • Scientific Publications

© 2020 Therapixel | Web design by Domaine-Pack.fr

Privacy Preference Center

Privacy Preferences